Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds: Miniperspective
Human cytomegalovirus (HCMV) infects individuals of all ages and establishes a lifelong
latency. Current antiviral drugs are suboptimal in efficacy and safety and ineffective against …
latency. Current antiviral drugs are suboptimal in efficacy and safety and ineffective against …
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds.
AD Jagtap, RJ Geraghty, Z Wang - Journal of Medicinal Chemistry, 2023 - europepmc.org
Human cytomegalovirus (HCMV) infects individuals of all ages and establishes a lifelong
latency. Current antiviral drugs are suboptimal in efficacy and safety and ineffective against …
latency. Current antiviral drugs are suboptimal in efficacy and safety and ineffective against …
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds
AD Jagtap, RJ Geraghty, Z Wang - Journal of medicinal chemistry, 2023 - experts.umn.edu
Human cytomegalovirus (HCMV) infects individuals of all ages and establishes a lifelong
latency. Current antiviral drugs are suboptimal in efficacy and safety and ineffective against …
latency. Current antiviral drugs are suboptimal in efficacy and safety and ineffective against …
Inhibiting HCMV pUL89-C Endonuclease with Metal-Binding Compounds
AD Jagtap, RJ Geraghty, Z Wang - Journal of medicinal chemistry - pubmed.ncbi.nlm.nih.gov
Human cytomegalovirus (HCMV) infects individuals of all ages and establishes a lifelong
latency. Current antiviral drugs are suboptimal in efficacy and safety and ineffective against …
latency. Current antiviral drugs are suboptimal in efficacy and safety and ineffective against …